H-AAGIGILTV^-OH

Rif. 3D-PP44948

Informazioni sul prodotto

• Nome: H-AAGIGILTV^-OH
• Sinonimi: NH2-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val^-OH

Descrizione

Peptide H-AAGIGILTV^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AAGIGILTV^-OH include the following: Rational design of peptide-based tumor vaccines WS Meng , LH Butterfield - Pharmaceutical research, 2002 - Springerhttps://link.springer.com/article/10.1023/A:1016497818471 Anti-melanoma cytotoxic T lymphocytes (CTL) recognize numerous antigenic peptides having'self'sequences: autoimmune nature of the anti-melanoma CTL response TJ Tsomides, EB Reilly, HN Eisen - International immunology, 1997 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/9/2/327/727863 Induction of melanoma-reactive CTL in HLA-A* 0201/K b transgenic mice by vaccination with peptides derived from MAGE-2 and MART-1 RPM Sutmuller, SH van der Burg , MJW Visseren - Immunology , 1997 - infona.plhttps://www.infona.pl/resource/bwmeta1.element.elsevier-b8764d78-8174-3548-9e3e-5a5b831cf1f6 Fluorescence labeling of anchor-modified Mart-1 peptide for increasing its affinity for HLA-A* 0201: Hit two targets with one arrow P Fattahi, N Salehi , Z Azizi - Journal of Peptide , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3480 Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition OY Borbulevych , FK Insaidoo, TK Baxter - Journal of molecular , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283607009497 Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes MJ Maeurer , HW Chan, J Karbach - European journal of , 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830261112 Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue MJ Maeurer , A Necker, RD Salter - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.1580 Terminal modifications inhibit proteolytic degradation of an immunogenic mart-127-35 peptide: Implications for peptide vaccines LH Brinckerhoff, VV Kalashnikov - journal of cancer, 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19991029)83:3%3C326::AID-IJC7%3E3.0.CO;2-X Mass-spectrometric evaluation of HLA-A* 0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100 JCA Skipper, PH Gulden - journal of cancer, 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19990827)82:5%3C669::AID-IJC9%3E3.0.CO;2-%23 Detection of antigen-specific T-cells with MHC/peptide-tetramer-complexes G Tully, E Jager, MJ Maeurer - Clinical and Applied Immunology Reviews, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1529104902000569 MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A* 0201-restricted, Melan-A-derived peptide after active intracellular processing G Held, A Wadle, N Dauth - European journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636545 TCR-induced alteration of primary MHC peptide anchor residue F Madura, PJ Rizkallah , M Legut - European journal of , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201948085 Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type E Jaeger, R Salter, C Castelli, H Höhn - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/6/2766/34711 Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8 T cells using HLA-A2 E Jager, R Salter, C Castelli, H Höhn, K Freitag - J. Immunol, 2002 - academia.eduhttps://www.academia.edu/download/47681918/Impact_of_antigen_presentation_on_TCR_mo20160731-32057-yvft53.pdf Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A E Jager, H Höhn, J Karbach, F Momburg - journal of cancer, 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19990611)81:6%3C979::AID-IJC22%3E3.0.CO;2-Y Peptide-specific CD8+ T-cell evolution in vivo: Response to peptide vaccination with Melan-A/MART-1 E Jager, H Höhn, A Necker, R Förster - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10165 Diversity of the fine specificity displayed by HLA-A* 0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide D Valmori, N Gervois, D Rimoldi - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/161/12/6956/1064 Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A* 0201-associated tyrosinase peptide 368-376 D Valmori, M J. Pittet , C Vonarbourg, D Rimoldi - Cancer research, 1999 - AACRhttps://aacrjournals.org/cancerres/article-abstract/59/16/4050/505392 Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues D Valmori, JF Fonteneau , CM Lizana - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/4/1750/905 The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer D Knight, AC Peterson, BI Rini , H Harlin - The , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pros.20864 A Novel Population of Human CDT Melanoma-Specific - J Immunol, 2007 - academia.eduhttps://www.academia.edu/download/74576885/7635.pdf Structural and functional characterization of peptide-beta2m fused HLA-A2/MART127-35 complexes C Shen, CC Chang, J Zhang, W Guo, L Xia - Biochemical and , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X06001999 Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells C Douat-Casassus, N Marchand-Geneste - Journal of medicinal , 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm0613368 Cytotoxic T Lymphocytes C Castelli, WJ Storkus , DM Martin, EC Huang - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191826/ Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A* 0201-binding peptides from the Melan-A/MART A van Elsas , SH van der Burg - European journal of , 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830260803 Allogeneic Cell Therapy with Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Malignant Melanoma A Nolte, J Slotty, C Beike, WE Berdel - in Hematology and , 2003 - Springerhttps://link.springer.com/chapter/10.1007/978-3-642-55774-3_5 Stability and CTL activity of N-terminal glutamic acid containing peptides A Beck , MC Bussat, C Klinguer-Hamour - Journal of Peptide , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-3011.2001.00895.x

• Marchio: Biosynth